Is China Traditional Chinese Medicine a central enterprise or a state-owned enterprise?

China traditional Chinese medicine is a central enterprise. According to the inquiry of the State Council SASAC, China Traditional Chinese Medicine Co., Ltd. is a wholly-owned subsidiary of China Pharmaceutical Group Co., Ltd. (hereinafter referred to as Sinopharm Group), a central enterprise directly managed by the State Council SASAC. China Pharmaceutical Group Co., Ltd. (hereinafter referred to as Sinopharm Group) is the only central enterprise directly managed by the State-owned Assets Supervision and Administration Commission of the State Council. It has a huge and healthy industrial chain, with 1600 member enterprises and 8 listed companies, with a total of more than 200,000 employees. Its business covers 3/kloc-0 provinces, autonomous regions and municipalities directly under the central government in China, and has established trade relations with many countries and regions in the world. In 20021year, Sinopharm Group achieved an operating income of more than 700 billion yuan, entered the top 100 enterprises in the world, ranking first among pharmaceutical enterprises in the world, and was rated as an "A-level enterprise for performance evaluation of central enterprises" by the State Council SASAC for eight consecutive years. As the national team, main force and pillar in the scientific and technological war against the COVID-19 epidemic, Sinopharm has always adhered to the principle of people-oriented and life-first, and made a major breakthrough in the fight against the epidemic, becoming the only enterprise in the world that independently developed four COVID-19 diagnostic reagents, four drugs and technologies for treating COVID-19 and four COVID-19 vaccines on the three epidemic prevention fronts of "diagnosis, treatment and prevention".